title: Long-term effect of rituximab in anti-mag polyneuropathy.
authors.affiliation: Department of Neurosciences, Ophthalmology and Genetics, University of Genova, Genova, Italy. luanabenedetti@libero.it
authors.forename: L
authors.initials: L
authors.lastname: Benedetti
authors.forename: C
authors.initials: C
authors.lastname: Briani
authors.forename: D
authors.initials: D
authors.lastname: Franciotta
authors.forename: M
authors.initials: M
authors.lastname: Carpo
authors.forename: L
authors.initials: L
authors.lastname: Padua
authors.forename: G
authors.initials: G
authors.lastname: Zara
authors.forename: R
authors.initials: R
authors.lastname: Zambello
authors.forename: M P
authors.initials: MP
authors.lastname: Sormani
authors.forename: G L
authors.initials: GL
authors.lastname: Mancardi
authors.forename: E
authors.initials: E
authors.lastname: Nobile-Orazio
authors.forename: A
authors.initials: A
authors.lastname: Schenone
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood*; D007155:Immunologic Factors / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D018992:Myelin-Associated Glycoprotein / Q000276:immunology*; D011115:Polyneuropathies / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D000069283:Rituximab; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007075:Immunoglobulin M; D007155:Immunologic Factors; D018992:Myelin-Associated Glycoprotein; D000069283:Rituximab